Restorative Neurotechnologies (RNT) has secured €3 million in Series A funding to advance the growth and market entry of its innovative digital therapy, MindLenses Professional™, aimed at cognitive rehabilitation for stroke patients and those with ADHD and dyslexia.

Target Information

Restorative Neurotechnologies (RNT) is a MedTech operator specializing in digital therapy platforms aimed at cognitive rehabilitation. The company has recently secured €3 million in a Series A funding round, which will accelerate the market entry and growth of its innovative digital therapy, MindLenses Professional™. This therapy focuses on rehabilitating cognitive functions in patients who have suffered strokes or are dealing with Attention Deficit Hyperactivity Disorder (ADHD) and dyslexia. Since its CE marking as a Class IIa Software as a Medical Device (SaMD) in 2023, MindLenses has already been adopted by 50 leading hospitals across Italy.

The funding will play a pivotal role in integrating MindLenses into healthcare systems across major European countries, facilitating broader access to its advanced therapeutic solutions.

Industry Overview

The acceptance of digital health solutions in Italy has rapidly evolved in the context of healthcare delivery. Given the increasing emphasis on efficiency and personalized treatment approaches, digital therapies are becoming indispens